Cargando…

Overcoming the challenges in translational development of natural killer cell therapeutics: An opinion paper

Detalles Bibliográficos
Autores principales: Qin, Hong, You, Changqiao, Yan, Feng, Tan, Kefang, Xu, Changgen, Zhao, Rui, Ekpo, Marlene Davis, Tan, Songwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755875/
https://www.ncbi.nlm.nih.gov/pubmed/36531041
http://dx.doi.org/10.3389/fonc.2022.1062765
_version_ 1784851517565566976
author Qin, Hong
You, Changqiao
Yan, Feng
Tan, Kefang
Xu, Changgen
Zhao, Rui
Ekpo, Marlene Davis
Tan, Songwen
author_facet Qin, Hong
You, Changqiao
Yan, Feng
Tan, Kefang
Xu, Changgen
Zhao, Rui
Ekpo, Marlene Davis
Tan, Songwen
author_sort Qin, Hong
collection PubMed
description
format Online
Article
Text
id pubmed-9755875
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97558752022-12-17 Overcoming the challenges in translational development of natural killer cell therapeutics: An opinion paper Qin, Hong You, Changqiao Yan, Feng Tan, Kefang Xu, Changgen Zhao, Rui Ekpo, Marlene Davis Tan, Songwen Front Oncol Oncology Frontiers Media S.A. 2022-12-02 /pmc/articles/PMC9755875/ /pubmed/36531041 http://dx.doi.org/10.3389/fonc.2022.1062765 Text en Copyright © 2022 Qin, You, Yan, Tan, Xu, Zhao, Ekpo and Tan https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Qin, Hong
You, Changqiao
Yan, Feng
Tan, Kefang
Xu, Changgen
Zhao, Rui
Ekpo, Marlene Davis
Tan, Songwen
Overcoming the challenges in translational development of natural killer cell therapeutics: An opinion paper
title Overcoming the challenges in translational development of natural killer cell therapeutics: An opinion paper
title_full Overcoming the challenges in translational development of natural killer cell therapeutics: An opinion paper
title_fullStr Overcoming the challenges in translational development of natural killer cell therapeutics: An opinion paper
title_full_unstemmed Overcoming the challenges in translational development of natural killer cell therapeutics: An opinion paper
title_short Overcoming the challenges in translational development of natural killer cell therapeutics: An opinion paper
title_sort overcoming the challenges in translational development of natural killer cell therapeutics: an opinion paper
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755875/
https://www.ncbi.nlm.nih.gov/pubmed/36531041
http://dx.doi.org/10.3389/fonc.2022.1062765
work_keys_str_mv AT qinhong overcomingthechallengesintranslationaldevelopmentofnaturalkillercelltherapeuticsanopinionpaper
AT youchangqiao overcomingthechallengesintranslationaldevelopmentofnaturalkillercelltherapeuticsanopinionpaper
AT yanfeng overcomingthechallengesintranslationaldevelopmentofnaturalkillercelltherapeuticsanopinionpaper
AT tankefang overcomingthechallengesintranslationaldevelopmentofnaturalkillercelltherapeuticsanopinionpaper
AT xuchanggen overcomingthechallengesintranslationaldevelopmentofnaturalkillercelltherapeuticsanopinionpaper
AT zhaorui overcomingthechallengesintranslationaldevelopmentofnaturalkillercelltherapeuticsanopinionpaper
AT ekpomarlenedavis overcomingthechallengesintranslationaldevelopmentofnaturalkillercelltherapeuticsanopinionpaper
AT tansongwen overcomingthechallengesintranslationaldevelopmentofnaturalkillercelltherapeuticsanopinionpaper